BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37226065)

  • 1. [Inflammatory Bowel Disease in elderly patients: Clinical characteristics and management in a tertiary hospital].
    Paredes-Méndez JE; Junes-Pérez SI; Vargas-Marcacuzco HTÁ; Villafuerte-Méndez EM
    Rev Gastroenterol Peru; 2023; 43(1):13-19. PubMed ID: 37226065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical and surgical management of moderate-to-severe inflamatory bowel disease].
    Paredes Méndez JE; Junes Pérez SI; Vargas Marcacuzco HT; Alosilla Sandoval PA; Gutiérrez Córdova IB; Fernández Luque JL; Alvarado Ortiz Blanco E
    Rev Gastroenterol Peru; 2021; 41(2):79-85. PubMed ID: 34724688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study.
    Niriella MA; Liyanage IK; Kodisinghe SK; De Silva AP; Jayatissa AVGAM; Navarathne NMM; Peiris RK; Kalubovila UP; Kumarasena SR; Jayasekara RW; de Silva HJ
    BMC Gastroenterol; 2021 Feb; 21(1):71. PubMed ID: 33593289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current therapy of inflammatory bowel disease in children.
    Rufo PA; Bousvaros A
    Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease.
    Ananthakrishnan AN; Shi HY; Tang W; Law CC; Sung JJ; Chan FK; Ng SC
    J Crohns Colitis; 2016 Oct; 10(10):1224-36. PubMed ID: 26928965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical spectrum of elderly-onset inflammatory bowel disease in India.
    Gupta YK; Singh A; Narang V; Midha V; Mahajan R; Mehta V; Singh D; Bansal N; Durairaj MVB; Dutta AK; Sood A
    Intest Res; 2023 Apr; 21(2):216-225. PubMed ID: 35929090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.
    Mañosa M; Calafat M; de Francisco R; García C; Casanova MJ; Huelín P; Calvo M; Tosca J; Fernández-Salazar L; Arajol C; Zabana Y; Bastida G; Hinojosa J; Márquez L; Barreiro-de-Acosta M; Calvet X; Monfort D; Gómez-Garcia MR; Rodríguez E; Huguet JM; Rojas-Feria M; Hervias D; Atienza R; Busquets D; Zapata E; Dueñas C; Charro M; Martínez-Cerezo FJ; Plaza R; Vázquez JM; Gisbert JP; Cañete F; Cabré E; Domènech E;
    Aliment Pharmacol Ther; 2018 Mar; 47(5):605-614. PubMed ID: 29369387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center.
    El-Atrebi KA; Taher E; El Aguizy FH; Ali RM; Hegazy A; El-Sayed MM; Eysa B; El-Atreby AA; Mohammed AA; El-Bassyouni HT
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(1):12-18. PubMed ID: 34887218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study.
    Pugliese D; Privitera G; Crispino F; Mezzina N; Castiglione F; Fiorino G; Laterza L; Viola A; Bertani L; Caprioli F; Cappello M; Barberio B; Ricci C; Balestrieri P; Daperno M; Pluchino D; Rizzello F; Scribano ML; Sablich R; Pastorelli L; Manguso F; Variola A; Di Sario A; Grossi L; Armuzzi A;
    Aliment Pharmacol Ther; 2022 Jul; 56(1):95-109. PubMed ID: 35876062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.
    Kariyawasam VC; Kim S; Mourad FH; Selinger CP; Katelaris PH; Brian Jones D; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Pathirana PW; Leong RW
    Inflamm Bowel Dis; 2019 Jul; 25(8):1390-1398. PubMed ID: 30597066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study.
    Li J; Liu Z; Hu P; Wen Z; Cao Q; Zou X; Chen Y; Wang Y; Zhong J; Shen X; Demuth D; Fadeeva O; Xie L; Chen J; Qian J
    BMC Gastroenterol; 2022 Feb; 22(1):44. PubMed ID: 35120446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva.
    Garrido A; Martínez MJ; Ortega JA; Lobato A; Rodríguez MJ; Guerrero FJ
    Rev Esp Enferm Dig; 2004 Oct; 96(10):687-91; 691-4. PubMed ID: 15537375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
    J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
    Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.